Conmed Corp.

Conmed Corp.

CNMD

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.33B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Conmed Corp.Conmed Corp.240.45%5%10.8
$37.50

Target Price by Analysts

20.4% downsideConmed Target Price DetailsTarget Price
$125.87

Current Fair Value

167% upside

Undervalued by 167% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.33 Billion
Enterprise Value$2.13 Billion
Dividend Yield$0.80 (0.45%)
Earnings per Share$1.52
Beta0.94
Outstanding Shares30,069,000

Return

Return on Equity5.43%ROE
Return on Assets2.46%
Return on Invested Capital6.26%

Valuation & Multiples

P/E Ratio23.98P/E Ratio
PEG311.31PEG
Price to Sales1.05Price to Sales
Price to Book Ratio1.39Price to Book Ratio
Enterprise Value to Revenue1.55
Enterprise Value to EBIT18.42
Enterprise Value to Net Income37
Total Debt to Enterprise0.39
Debt to Equity0.8Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 29, 2026
EPS Estimate
$1.11
Average shareholder expectation
Revenue Estimate
$337.60 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$1.00
Average shareholder expectation
Revenue Estimate
$336.28 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.15%▼ 112.86%
Total Invested$2.11M▼ 99.81%
Investors Holding11▼ 240.00%

ESG Score

No data

About Conmed Corp.

CEO: Curt Hartman